A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

Clinical trial NCT03845400 · COMPLETED

Trial details

NCT number: NCT03845400
Sponsor: Shire
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Angioedema (HAE)

Start date: 2019-03-30
Primary completion: 2022-10-22
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.